PDS Biotech CMO Lauren Wood retires; Kirk Shepard appointed as new CMO

PDS Biotechnology Corp

Lauren V. Wood, M.D. retired as CMO effective January 22, 2024; departure not related to any disagreement.
Kirk V. Shepard, M.D. appointed as CMO effective January 22, 2024; board-certified oncologist with >30 years industry experience.
Inducement Plan amended to increase reserved shares from 1,100,000 to 2,100,000 shares of common stock.
Dr. Shepard granted nonstatutory stock options to purchase 200,000 shares at $4.49 (closing price on grant date).

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Lauren V. Wood

Chief Medical Officer

PDSB · PDS Biotechnology Corp

Effective: 2024-01-22
Filed: January 22, 2024, 6:59 PM ET

Effective as of January 22, 2024, Lauren V. Wood, M.D. retired from her position as Chief Medical Officer of PDS Biotechnology Corporation (the “Company”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lauren V. Wood retired as Chief Medical Officer at PDS Biotechnology Corp.

Action: retired
Role: Chief Medical Officer

Exact text from the filing

Effective as of January 22, 2024, Lauren V. Wood, M.D. retired from her position as Chief Medical Officer of PDS Biotechnology Corporation (the “Company”).

View on SEC.gov

PDS Biotechnology Corp filing history →

Source: SEC EDGAR

accession 0001140361-24-003165

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.